SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001042074-17-000007
Filing Date
2017-06-30
Accepted
2017-06-30 13:04:01
Documents
2
Period of Report
2017-06-26

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT primary_doc.html 3  
1 PRIMARY DOCUMENT primary_doc.xml 3 1508
2 POWER OF ATTORNEY klara.txt EX-24 3201
  Complete submission text file 0001042074-17-000007.txt   6250
Mailing Address 7999 GATEWAY BLVD SUITE 130 NEWARK CA 94560
Business Address 7999 GATEWAY BLVD SUITE 130 NEWARK CA 94560 510-293-8800
CymaBay Therapeutics, Inc. (Issuer) CIK: 0001042074 (see all company filings)

IRS No.: 943103561 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 7999 GATEWAY BOULEVARD, SUITE 130 NEWARK CA 94560
Business Address
Dickinson Klara (Reporting) CIK: 0001339895 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-36500 | Film No.: 17941275